Dare Bioscience Stock Quote DARE - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

3.63

Bid

3.50

Ask

3.98

Volume

9,111

3.55 Day's Range 3.64

3.05 52 Week Range 9.474

Market Cap

30.581M

Previous Close

3.60

Open

3.64

Last Trade

3.98

Last Trade Time

Financial Volume

$ 32,873

VWAP

3.6081

Average Volume (3m)

382,671

Shares Outstanding

8,424,408

Dividend Yield

PE Ratio

-1.01

Earnings Per Share (EPS)

-3.58

Revenue

2.81M

Net Profit

-30.16M

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve... Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.darebioscience.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Dare Bioscience Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DARE. The last closing price for Dare Bioscience was $3.60. Over the last year, Dare Bioscience shares have traded in a share price range of $ 3.05 to $ 9.474.

Dare Bioscience currently has 8,424,408 shares outstanding. The market capitalization of Dare Bioscience is $30.33 million. Dare Bioscience has a price to earnings ratio (PE ratio) of -1.01.

Daré Bioscience Announces Publication in Obstetrics & Gynecology of Phase 2b Study Efficacy Results of Topical Sildenafil Cream, 3.6% for the Treatment of Female Sexual Arousal Disorder

Phase 2b study demonstrated topical Sildenafil Cream, 3.6% improved outcomes among women with female sexual arousal disorder (FSAD), particularly in an exploratory subset of women with FSAD with...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.43	13.4375	3.2	3.855	3.2	46357	3.59412432	CS
4	0.2	5.83090379009	3.43	4.08	3.05	55405	3.47405197	CS
12	-0.204	-5.32081377152	3.834	7.56	3.05	382671	4.99682776	CS
26	-0.45	-11.0294117647	4.08	7.56	3.05	521194	4.71499627	CS
52	-5.4192	-59.8859567697	9.0492	9.474	3.05	463017	4.82330734	CS
156	-14.13	-79.5608108108	17.76	30.12	3.05	1228001	18.08789447	CS
260	-5.85	-61.7088607595	9.48	46.2	3.05	1497459	19.68306932	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.55M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.51M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	258.51k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.05M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.68M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.89M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	714.54k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.01M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	404.94M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.51M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.16M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.42M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.64M